Skip to content
SEC filings edition: Friday, November 13, 2026 · 767 companies with filings Publisher's serviceBoardeon, your AI board · Hire your board →
Monday, November 16, 2026Every business day from SEC EDGAR
SEC EDGAR · Nov 13, 2026 1bankruptcies 11delisting notices 12late filings 43leadership changes 6IPO filings 199private raises 90earnings releases
Company page · CIK 1253689 · CBIO

Crescent Biopharma, Inc.

Filing with the SEC SEC-reporting company Waltham, MA Nasdaq
An email when it files something new with the SEC. Your account

What this means

  • In the filings we classify there is no bankruptcy, debt default, delisting notice, late filing notice or restatement for this company.

What to do next

Guides from the Companies Daily newsroom, picked for what the register shows.

Financials from XBRL

Calendar-year frame20252024
Revenue$10.8M—
Net income (loss)$154K$38K
Total assets$240M$35.6M
Total liabilities$37.3M$47.1M
Stockholders’ equity$203M−$15.5M
Cash and equivalents$213M$34.8M

From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.

Name as filed
CRESCENT BIOPHARMA, INC.
Formerly: Glycomimetics Inc
CIK
0001253689
Tickers
CBIO
Kind of filer
SEC-reporting company
Non-accelerated filer; Smaller reporting company
Status
Filing with the SEC
State of incorporation
Cayman Islands
Business address
Waltham, Massachusetts
Industry (SIC)
2834 · Pharmaceutical preparations
Industry: D · Manufacturing →
Fiscal year ends
December 31
Last annual report
10-K for the period ended Dec 31, 2025
Last quarterly report
10-Q for the quarter ended Sep 30, 2026
Bankruptcy reported
Not in our data
Last edition event
Nov 12, 2026

Filing history

Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.

  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2026
    Form 10-Q · filed Nov 12, 2026 · filing · edition of Nov 12, 2026
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 12, 2026 · filing · edition of Nov 12, 2026
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Jul 30, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2026
    Form 10-Q · filed Jul 30, 2026 · filing
  • Results announced
    Form 8-K · items 2.02 · filed Jul 14, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2026
    Form 10-Q · filed Apr 29, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Apr 29, 2026 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2025
    Form 10-K · filed Feb 26, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Feb 26, 2026 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Jan 7, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 6, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2025
    Form 10-Q · filed Nov 6, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2025
    Form 10-Q · filed Jul 31, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 2.02, 5.02, 9.01 · filed Jul 31, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 5.02, 9.01 · filed Jul 31, 2025 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SCHEDULE 13D · filed Jun 23, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 1.01, 2.01, 2.02, 3.03, 4.01, 5.01, 5.02, 5.03, 5.05, 5.06, 7.01, 9.01 · filed Jun 18, 2025 · filing
  • Change in control
    Form 8-K · items 1.01, 2.01, 2.02, 3.03, 4.01, 5.01, 5.02, 5.03, 5.05, 5.06, 7.01, 9.01 · filed Jun 18, 2025 · filing
  • Change of auditor
    Form 8-K · items 1.01, 2.01, 2.02, 3.03, 4.01, 5.01, 5.02, 5.03, 5.05, 5.06, 7.01, 9.01 · filed Jun 18, 2025 · filing
  • Results announced
    Form 8-K · items 1.01, 2.01, 2.02, 3.03, 4.01, 5.01, 5.02, 5.03, 5.05, 5.06, 7.01, 9.01 · filed Jun 18, 2025 · filing
  • Acquisition or disposal completed
    Form 8-K · items 1.01, 2.01, 2.02, 3.03, 4.01, 5.01, 5.02, 5.03, 5.05, 5.06, 7.01, 9.01 · filed Jun 18, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2025
    Form 10-Q · filed May 14, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 1.02, 5.02 · filed Feb 25, 2025 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2024
    Form 10-K · filed Feb 13, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Jan 31, 2025 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Dec 26, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2024
    Form 10-Q · filed Nov 13, 2024 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SC 13D · filed Nov 4, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 1.01, 3.02, 5.01, 5.02, 7.01, 8.01, 9.01 · filed Oct 29, 2024 · filing
  • Change in control
    Form 8-K · items 1.01, 3.02, 5.01, 5.02, 7.01, 8.01, 9.01 · filed Oct 29, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2024
    Form 10-Q · filed Aug 8, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 2.05, 5.02, 7.01, 9.01 · filed Jul 30, 2024 · filing
  • Restructuring or layoffs
    Form 8-K · items 2.05, 5.02, 7.01, 9.01 · filed Jul 30, 2024 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Jun 26, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Jun 13, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2024
    Form 10-Q · filed May 9, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 7.01, 9.01 · filed May 6, 2024 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2023
    Form 10-K · filed Mar 27, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Mar 27, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2023
    Form 10-Q · filed Nov 3, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 3, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2023
    Form 10-Q · filed Aug 2, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 2, 2023 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2023
    Form 10-Q · filed May 3, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed May 3, 2023 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2022
    Form 10-K · filed Mar 29, 2023 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Mar 29, 2023 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Feb 21, 2023 · filing